Three more Legionnaires’ cases reported at Mount Carmel Grove City Hospital

One person who contracted Legionnaires’ has died


Three more cases of Legionnaires’ disease have been confirmed at Mount Carmel Grove City Hospital, in Grove City, Ohio, raising the total to 10 cases, according to an article on the Columbus Dispatch website.

One person who contracted Legionnaires’ has died, according to Franklin County Public Health.

Mount Carmel Health Systems initially announced Friday that there were seven victims of the disease at the new $361 million hospital that opened April 28. 

It is believed that patients were exposed sometime between April 27 and May 24.

Read the article.



June 10, 2019


Topic Area: Infection Control


Recent Posts

Healthcare Workers Need Better Workplaces

New global survey finds frontline healthcare workers struggle with significant gaps in workplace satisfaction.


Protecting Patients Through Design and Compliance at Altru Health System

Case study: Altru Health System’s new “Hospital in the Park” pairs patient-focused design with durable, code-compliant exit solutions built for safety, performance and long-term flexibility.


Novant Health's $1B Expansion Plans Approved

The approval supports the master facility plan for Novant Health New Hanover Regional Medical Center.


What Lies Ahead for Healthcare Facilities Managers

Staffing shortages, rising regulatory scrutiny and accelerating adoption of AI are converging to reshape the way healthcare facilities are managed.


What's in the Future for Healthcare Restrooms?

Workforce shortages, rising hygiene expectations and connected technologies are pushing healthcare restrooms beyond basic utility.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.